This site is intended for healthcare professionals only
LoginRegister
Zydus Bags USFDA Nod for Eltrombopag Tablets Across Four StrengthsZydus, CSIR-CDRI Lucknow to develop drug for Chronic Kidney Disease induced Osteoporosis
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon gets 4 USFDA observations for Bengaluru facility
Pfizer INDovation Awards Grants of over Rs 8 Cr to 14 Indian Startups to Drive Next-Gen Healthcare InnovationPfizer gets CDSCO Panel nod to study antimicrobial FDC Avibactam plus Aztreonam
CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to QueriesIRGMA Welcomes CDSCO's New Guidelines, Urges to stop import of substandard gloves
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma arm Telangana facility gets 10 USFDA observations
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsUSFDA concludes inspection at Biocon Biologics Malaysia Insulins facility
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA issues EIR for Piramal Pharma Ahmedabad facility
Lalitpur Pharma ParkZydus Lifesciences gets USFDA nod for prostate cancer drug Enzalutamide
Eris LifesciencesEris Lifscience Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC
AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter MarketAbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small...
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSanofi, Regeneron get USFDA nod for Dupixent for COPD
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsUSFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
X